Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
| ▸ | IDH1 | O75874 | 1/20 | 0.30 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20521131 | 0.95 | MAPT (0.38) | L3MBTL1ALDH1A1AKT1MAPTLMNA | |
| SCHEMBL4389892 | 0.90 | AKT1 (0.34) | ALDH1A1AKT1MAPTLMNAHPGD | |
| SCHEMBL20521982 | 0.76 | TDP1 (0.53) | L3MBTL1MAPTTDP1 | |
| SCHEMBL656697 | 0.73 | MAOA (0.42) | L3MBTL1ALDH1A1AKT1MAPTLMNA | |
| SCHEMBL9303552 | 0.73 | CES2 (0.46) | L3MBTL1ALDH1A1MAPTLMNAHPGD | |
| SCHEMBL4758846 | 0.72 | SMN1; SMN2 (0.44) | ALDH1A1MAPTTDP1HPGD | |
| SCHEMBL2745649 | 0.72 | TDP1 (0.64) | L3MBTL1ALDH1A1AKT1MAPTLMNA | |
| SCHEMBL27827293 | 0.69 | HDAC3 (0.32) | AKT1 | |
| SCHEMBL27686537 | 0.69 | HDAC3 (0.32) | AKT1 | |
| SCHEMBL9303827 | 0.69 | ATM (0.43) | L3MBTL1ALDH1A1MAPTLMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121574291-A | Borate activated metallocene catalysts | 博里利斯股份公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-110494458-B | Alumoxane-activated metallocene catalysts | 博里利斯股份公司 | 2023-08-15 | — | — | CN | disclosed |
| EP-3601385-B1 | BORATE-ACTIVATED METALLOCENE CATALYSTS | BOREALIS AG (AT) | 2023-05-03 | — | — | EP | disclosed |
| EP-3601384-B1 | ALUMINOXANE-ACTIVATED METALLOCENE CATALYSTS | BOREALIS AG (AT) | 2023-05-03 | — | — | EP | disclosed |
| EP-3601384-B1 | ALUMINOXANE-ACTIVATED METALLOCENE CATALYSTS | BOREALIS AG (AT) | 2023-05-03 | — | — | EP | disclosed |
| US-11560440-B2 | Aluminoxane-activated metallocene catalysts | BOREALIS AG (AT) | 2023-01-24 | — | — | US | disclosed |
| US-11192963-B2 | Borate-activated metallocene catalysts | BOREALIS AG (AT) | 2021-12-07 | — | — | US | disclosed |
| US-20210108006-A1 | BORATE-ACTIVATED METALLOCENE CATALYSTS | BOREALIS AG (AT) | 2021-04-15 | — | — | US | disclosed |
| US-20210095057-A1 | ALUMINOXANE-ACTIVATED METALLOCENE CATALYSTS | BOREALIS AG (AT) | 2021-04-01 | — | — | US | disclosed |
| EP-3601385-A1 | BORATE-ACTIVATED METALLOCENE CATALYSTS | Borealis AG (AT) | 2020-02-05 | — | — | EP | disclosed |
| EP-1778606-B1 | SYNTHESIS OF 6-ARYL-6-ALKYL FULVENES, 6-ARYL-6-ALKENYL FULVENES, AND RELATED COMPOUNDS | CHEVRON PHILLIPS CHEMICAL CO (US) | 2009-11-25 | — | — | EP | disclosed |
| US-7420097-B2 | Synthesis of 6-aryl-6-alkyl fulvenes, 6-aryl-6-alkenyl fulvenes, and related compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2008-09-02 | — | — | US | disclosed |
| CN-1997614-A | Synthesis of 6-aryl-6-alkyl fulvenes, 6-aryl-6-alkenyl fulvenes, and related compounds | CHEVRON PHILLIPS CHEMICAL CO (US) | 2007-07-11 | — | — | CN | disclosed |
| CN-1989158-A | Polymerization catalysts for producing polymers with low levels of long chain branching | CHEVRON PHILLIPS CHEMICAL CO (US) | 2007-06-27 | — | — | CN | disclosed |
| EP-1778749-A2 | POLYMERIZATION CATALYSTS FOR PRODUCING POLYMERS WITH LOW LEVELS OF LONG CHAIN BRANCHING | Chevron Phillips Chemical Company LP (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1778606-A1 | SYNTHESIS OF 6-ARYL-6-ALKYL FULVENES, 6-ARYL-6-ALKENYL FULVENES, AND RELATED COMPOUNDS | Chevron Phillips Chemical Company (US) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006004709-A2 | POLYMERIZATION CATALYSTS FOR PRODUCING POLYMERS WITH LOW LEVELS OF LONG CHAIN BRANCHING | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2006-01-12 | — | — | WO | disclosed |
| WO-2006004669-A1 | IMPROVED SYNTHESIS OF 6-ARYL-6-ALKYL FULVENES, 6-ARYL-6-ALKENYL FULVENES, AND RELATED COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2006-01-12 | — | — | WO | disclosed |
| US-20050288524-A1 | Synthesis of 6-aryl-6-alkyl fulvenes, 6-aryl-6-alkenyl fulvenes, and related compounds | CHEVRON PHILLIPS CHEMICAL COMPANY | 2005-12-29 | — | — | US | disclosed |
| US-20050288461-A1 | Polymerization catalysts for producing polymers with low levels of long chain branching | CHEVRON PHILLIPS CHEMICAL COMPANY, L.P. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288524-A1 | Synthesis of 6-aryl-6-alkyl fulvenes, 6-aryl-6-alkenyl fulvenes, and related compounds | ANXA6, ARSA, CYP2A6 | L3MBTL1 1918/4885ALDH1A1 2633/4885AKT1 3978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.